CooperCompanies Slides as Reduced Outlook and CooperSurgical Decision Weigh on Shares

CooperCompanies (COO) is down 19.3% today. Here is some analysis on what might have caused this price movement.

Analysis: The sharp drop appears tied mainly to a weaker-than-expected outlook after fiscal third-quarter results, along with investor disappointment that the company chose to keep CooperSurgical instead of pursuing a sale. The combination likely overshadowed an earnings-per-share beat and an expanded buyback plan.

Details:

Management updated fiscal 2026 guidance to non-GAAP EPS of $4.51 to $4.55 and revenue of $4.229 billion to $4.252 billion, which pointed to only modest organic growth for the year.

Fourth-quarter guidance was also soft, with non-GAAP EPS projected at $1.05 to $1.09 and total revenue of $1.057 billion to $1.080 billion.

The board completed its strategic review and decided to retain CooperSurgical, saying offers received were not attractive enough and citing valuation pressure from a new non-hormonal IUD competitor and the recent fertility litigation settlement.

The company also increased its share repurchase authorization to $3 billion and said it had already repurchased substantial stock this fiscal year, but that capital return signal did not appear strong enough to offset concerns about growth and the review outcome.

Sources:

CooperCompanies, MarketScreener, Investing.com

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$COO Hedge Fund Activity

We have seen 372 institutional investors add shares of $COO stock to their portfolio, and 404 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

CAPITAL WORLD INVESTORS removed 6,823,821 shares (-92.0%) from their portfolio in Q2 2026, for an estimated $489,336,203
NEUBERGER BERMAN GROUP LLC removed 3,040,517 shares (-89.6%) from their portfolio in Q2 2026, for an estimated $218,035,474
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP added 1,878,057 shares (+88.3%) to their portfolio in Q2 2026, for an estimated $134,675,467
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 1,843,969 shares (+inf%) to their portfolio in Q2 2026, for an estimated $132,231,016
BARCLAYS PLC added 1,787,487 shares (+537.4%) to their portfolio in Q2 2026, for an estimated $128,180,692
GATES CAPITAL MANAGEMENT, INC. added 1,688,589 shares (+inf%) to their portfolio in Q2 2026, for an estimated $121,088,717
BLACKROCK, INC. removed 1,588,676 shares (-9.6%) from their portfolio in Q2 2026, for an estimated $113,923,955

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$COO Congressional Stock Trading

Members of Congress have traded $COO stock 3 times in the past 6 months. Of those trades, 3 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $COO stock by members of Congress over the last 6 months:

REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 2 times. They made 2 purchases worth up to $30,000 on 06/05, 05/29 and 0 sales.
SENATOR ALAN ARMSTRONG purchased up to $15,000 on 03/27.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.

$COO Price Targets

Multiple analysts have issued price targets for $COO recently. We have seen 9 analysts offer price targets for $COO in the last 6 months, with a median target of $85.0.

Here are some recent targets:

Joanne Wuensch from Citigroup set a target price of $76.0 on 07/08/2026
Navann Ty from BNP Paribas set a target price of $92.0 on 06/08/2026
Larry Biegelsen from Wells Fargo set a target price of $66.0 on 06/05/2026
David Saxon from Needham set a target price of $86.0 on 06/05/2026
Jeff Johnson from Baird set a target price of $85.0 on 06/05/2026
Jonathan Block from Stifel set a target price of $85.0 on 06/05/2026
Robbie Marcus from JP Morgan set a target price of $71.0 on 06/05/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.